Managing Multiple Myeloma: How Pharmacists Drive Success in Optimizing Patient Care : Episode 1

Treatment Landscape for Transplant-Eligible Patients with NDMM

September 27, 2024

By Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Amir Ali, PharmD, BCOP

Opinion

Video

Panelists discuss how the current first-line treatment options for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM) typically involve combination therapies including proteasome inhibitors, immunomodulatory drugs, and steroids.

Now Viewing

EP: 1.Treatment Landscape for Transplant-Eligible Patients with NDMM

EP: 2.Frontline Treatment and Sequencing Therapy

Video content above is prompted by the following:

Provide a brief overview of first-line treatment options currently available for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM).